Recurrent Clear Cell Meningioma of Cauda Equina in a Middle-Aged Gentleman
Keywords:
Clear cell meningioma, cauda equina, laminectomy, meningiomaAbstract
Clear cell meningioma of the cauda equina is an infrequent occurrence. It falls under the Central Nervous System WHO Grade 2, 5th Edition WHO Classification. This type of meningioma is known for its aggressive nature, frequent recurrence, and instances of leptomeningeal metastasis. The radiological findings resemble typical meningioma, but specific indicators of clear cell meningioma include leptomeningeal enhancement, although this feature is not exclusive to it. Therefore, the diagnosis primarily relies on histopathology. Here, we present a case of a 58-year-old local male with a history of laminectomy and excision of clear cell meningioma of the cauda equina.
References
Alsadiq MN, Albarbari ZS, Alshakhs F, Alduayji MA, Al-Umran S, Alenzi A: Spinal clear cell meningioma: Atypical clinical and radiological manifestations. Case Rep Surg 2021:9998399, 2021
Bettaswamy G, Ambesh P, Das KK, Sahu R, Srivastava A, Mehrotra A, Jaiswal A, Jaiswal S, Behari S: Extradural spinal meningioma: Revisiting a rare entity. J Craniovertebr Junction Spine 7(1):65-68, 2016
Chen HK, Wu YT, Lin YJ, Lin JW: Clear cell meningioma with frequent chordoid features and aggressive behavior: A clinicopathologic study of ten cases at a single institution. J Neurooncol 103(3):551-559, 2011
Compston A: Aids to the investigation of peripheral nerve injuries. Medical research council: Nerve injuries research committee. His majesty's stationery office: 1942; pp. 48 (iii) and 74 figures and 7 diagrams; with aids to the examination of the peripheral nervous system. By michael o'brien for the guarantors of brain. Saunders elsevier: 2010; pp. [8] 64 and 94 figures. Brain 133(10):2838-2844, 2010
El Khamary SM, Alorainy IA: Case 100: Spinal epidural meningioma. Radiology 241(2):614-617, 2006
Gerkes EH, Fock JM, den Dunnen WF, van Belzen MJ, van der Lans CA, Hoving EW, Fakkert IE, Smith MJ, Evans DG, Olderode-Berends MJ: A heritable form of smarce1-related meningiomas with important implications for follow-up and family screening. Neurogenetics 17(2):83-89, 2016
Harkin JC, Leonard GL: Abnormal amianthoid collagen fibers in meningioma. Acta Neuropathol 76(6):638-639, 1988
Hartmann C, Sieberns J, Gehlhaar C, Simon M, Paulus W, von Deimling A: Nf2 mutations in secretory and other rare variants of meningiomas. Brain Pathol 16(1):15-19, 2006
Jain D, Sharma MC, Sarkar C, Suri V, Garg A, Singh M, Sharma BS, Mahapatra AK: Clear cell meningioma, an uncommon variant of meningioma: A clinicopathologic study of nine cases. J Neurooncol 81(3):315-321, 2007
Kamiya K, Inagawa T, Nagasako R: Malignant intraventricular meningioma with spinal metastasis through the cerebrospinal fluid. Surg Neurol 32(3):213-218, 1989
Li MH, Holtås S, Larsson EM: Mr imaging of intradural extramedullary tumors. Acta Radiol 33(3):207-212, 1992
Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW: The 2016 world health organization classification of tumors of the central nervous system: A summary. Acta Neuropathol 131(6):803-820, 2016
Louis DN, Perry A, Wesseling P, Brat DJ, Cree IA, Figarella-Branger D, Hawkins C, Ng HK, Pfister SM, Reifenberger G, Soffietti R, von Deimling A, Ellison DW: The 2021 who classification of tumors of the central nervous system: A summary. Neuro Oncol 23(8):1231-1251, 2021
Matsui H, Kanamori M, Abe Y, Sakai T, Wakaki K: Multifocal clear cell meningioma in the spine: A case report. Neurosurg Rev 21(2-3):171-173, 1998
Miller AA, Ramsden F: Malignant meningioma with extracranial metastases and seeding of the subarachnoid space and the ventricles. Pathol Eur 7(2):167-175, 1972
Smith MJ, Ahn S, Lee JI, Bulman M, Plessis DD, Suh YL: Smarce1 mutation screening in classification of clear cell meningiomas. Histopathology 70(5):814-820, 2017
Tao X, Dong J, Hou Z, Hao S, Zhang J, Wu Z, Liu B: Clinical features, treatment, and prognostic factors of 56 intracranial and intraspinal clear cell meningiomas. World Neurosurg 111:e880-e887, 2018
Tauziede-Espariat A, Parfait B, Besnard A, Lacombe J, Pallud J, Tazi S, Puget S, Lot G, Terris B, Cohen J, Vidaud M, Figarella-Branger D, Monnien F, Polivka M, Adle-Biassette H, Varlet P: Loss of smarce1 expression is a specific diagnostic marker of clear cell meningioma: A comprehensive immunophenotypical and molecular analysis. Brain Pathol 28(4):466-474, 2018
Yu KB, Lim MK, Kim HJ, Suh CH, Park HC, Kim EY, Han HS: Clear-cell meningioma: Ct and mr imaging findings in two cases involving the spinal canal and cerebellopontine angle. Korean J Radiol 3(2):125-129, 2002
Zhang GJ, Zhang YS, Zhang GB, Yan XJ, Li CB, Zhang LW, Li D, Wu Z, Zhang JT: Prognostic factors, survival, and treatment for intracranial world health organization grade ii chordoid meningiomas and clear-cell meningiomas. World Neurosurg 117:e57-e66, 2018
Zhang H, Ma L, Shu C, Dong LQ, Ma YQ, Zhou Y: Spinal clear cell meningiomas: Clinical features and factors predicting recurrence. World Neurosurg 134:e1062-e1076, 2020
Zhang H, Ma L, Wang YB, Shu C, Kuang W, Huang YA, Dong LQ, Cheng GG: Intracranial clear cell meningiomas: Study on clinical features and predictors of recurrence. World Neurosurg 97:693-700.e611, 2017
Downloads
Additional Files
Published
Issue
Section
License
JBCS Publication Ethics
JBCS is committed to ensure the publication process follows specific academic ethics. Hence, Authors, Reviewers and Editors are required to conform to standards of ethical guidelines.
Authors
Authors should discuss objectively the significance of research work, technical detail and relevant references to enable others to replicate the experiments. JBCS do not accept fraudulent or inaccurate statements that may constitute towards unethical conduct.
Authors should ensure the originality of their works. In cases where the work and/or words of others have been used, appropriate acknowledgements should be made. JBCS do not accept plagiarism in all forms that constitute towards unethical publishing of an article.
This includes simultaneous submission of the same manuscript to more than one journal. Corresponding author is responsible for the full consensus of all co-authors in approving the final version of the paper and its submission for publication.
Reviewers
Reviewers of JBCS treat manuscripts received for review as confidential documents. Therefore, Reviewers must ensure the confidentiality and should not use privileged information and/or ideas obtained through peer review for personal advantage.
Reviews should be conducted based on academic merit and observations should be formulated clearly with supporting arguments. In cases where selected Reviewer feels unqualified to review a manuscript, Reviewer should notify the editor and excuse himself from the review process in TWO (2) weeks time from the review offer is made.
In any reasonable circumstances, Reviewers should not consider to evaluate manuscripts if they have conflicts of interest (i.e: competitive, collaborative and/or other connections with any of the authors, companies, or institutions affiliated to the papers).
Editors
Editors should evaluate manuscripts exclusively based on their academic merit. JBCS strictly do not allow editors to use unpublished information of authors without the written consent of the author. Editors are required to take appropriate responsive actions if ethical complaints have been presented concerning a submitted manuscript or published paper.
CONFLICT OF INTEREST
Journal of Biomedical and Clinical Sciences requires authors to declare all competing interests in relation to their work. All submitted manuscripts must include a ‘competing interests section at the end of the manuscript listing all competing interests (financial and non-financial). Where authors have no competing interests, the statement should read ,The authors have declared that no competing interests exist. Editors may ask for further information relating to competing interests.
Editors and reviewers are also required to declare any competing interests and will be excluded from the peer review process if a competing interest exists. Competing interests may be financial or non-financial. A competing interest exists when the authors interpretation of data or presentation of information may be influenced by their personal or financial relationship with other people or organizations. Authors should disclose any financial competing interests but also any non-financial competing interests that may cause them embarrassment if they were to become public after the publication of the article.
HUMAN AND ANIMAL RIGHTS
All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow the Misconduct policy and may reject the manuscript, and/or contact the author(s) institution or ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.
Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee. A statement detailing this, including the name of the ethics committee and the reference number where appropriate, must appear in all manuscripts reporting such research. Further information and documentation to support this should be made available to Editors on request.
Experimental research on vertebrates or any regulated invertebrates must comply with institutional, national, or international guidelines, and where available should have been approved by an appropriate ethics committee. The Basel Declaration outlines fundamental principles to adhere to when conducting research in animals and the International Council for Laboratory Animal Science (ICLAS) has also published ethical guidelines.
A statement detailing compliance with relevant guidelines (e.g. the revised Animals (Scientific Procedures) Act 1986 in the UK and Directive 2010/63/EU in Europe) and/or ethical approval (including the name of the ethics committee and the reference number where appropriate) must be included in the manuscript. The Editor will take account of animal welfare issues and reserves the right to reject a manuscript, especially if the research involves protocols that are inconsistent with commonly accepted norms of animal research. In rare cases, Editors may contact the ethics committee for further information.
INFORMED CONSENT
For all research involving human subjects, informed consent to participate in the study should be obtained from participants (or their parent or guardian in the case of children under 16) and a statement to this effect should appear in the manuscript, this includes to all manuscripts that include details, images, or videos relating to individual participants.
DATA SHARING POLICY
JBCS strongly encourages that all datasets on which the conclusions of the paper rely should be available to readers. We encourage authors to ensure that their datasets are either deposited in publicly available repositories (where available and appropriate) or presented in the main manuscript or additional supporting files, in machine-readable format (such as spreadsheets rather than PDFs) whenever possible
Authors who do not wish to share their data must state that data will not be shared, and give the reason.
COPYRIGHT NOTICE
The JBCS retains the copyright of published manuscripts under the terms of the Copyright Transfer Agreement. However, the journal permits unrestricted use, distribution, and reproduction in any medium, provided permission to reuse, distribute and reproduce is obtained from the Journal's Editor and the original work is properly cited.
While the advice and information in this journal are believed to be true and accurate on the date of its going to press, neither the authors, the editors, nor the publisher can accept any legal responsibility for any errors or omissions that may be made. The publisher makes no warranty, express or implied, with respect to the material contained herein.
Copyright (c) 2023 Journal of Biomedical and Clinical Sciences (JBCS)
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
